Home » Newsletters » BioWorld

BioWorld

Dec. 20, 1994

View Archived Issues

PHARMOS REPORTS ENCOURAGING DATA FOR OPHTHALMIC PRODUCT

UK'S BIOINDUSTRY ASSOCIATION RECRUITS NEW CHIEF EXECUTIVE

JUST-DISCOVERED TWO-WAY TRAFFIC ROUTE INSIDE CELL LEADS TO CHOLESTEROL

ATHENA ACQUIRING NEUROLOGY DIAGNOSTICS COMPANY

EFFICACY OF GP120 AIDS VACCINE MAY FINALLY BE TESTED

RESEARCHERS DISCOVER GENE LINKED TO LOW-GRADE LEUKEMIA

IMMUNOGEN LAYS OFF 100 EMPLOYEES TO REDUCE EXPENSES

CORVAS, SCHERING-PLOUGH ALIGN FOR CARDIOVASCULAR DRUGS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...